Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue
暂无分享,去创建一个
E. Rakoczy | P. Rakoczy | Xiaohuai Zhou | C. Lai | T. Redmond | N. Barnett | T Michael Redmond | M. Brankov | K. Narfstrōm | M. J. Yu | Xiaohua Zhou
[1] W. Shen,et al. Impurity of recombinant adeno-associated virus type 2 affects the transduction characteristics following subretinal injection in the rat , 2004, Vision Research.
[2] D. Charteris,et al. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina , 2003, Gene Therapy.
[3] K. Narfström,et al. Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results , 2003, Documenta Ophthalmologica.
[4] I. Constable,et al. Practical considerations of recombinant adeno‐associated virus‐mediated gene transfer for treatment of retinal degenerations , 2003, The journal of gene medicine.
[5] W. Hauswirth,et al. Structural and functional protection of photoreceptors from MNU-induced retinal degeneration by the X-linked inhibitor of apoptosis. , 2003, Investigative ophthalmology & visual science.
[6] Y. Chérel,et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] M. Seeliger,et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. , 2003, Investigative ophthalmology & visual science.
[8] Jian-xing Ma,et al. Correlation of regenerable opsin with rod ERG signal in Rpe65-/- mice during development and aging. , 2002, Investigative ophthalmology & visual science.
[9] P. Boulanger,et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] Jian-xing Ma,et al. 11-cis-Retinal Reduces Constitutive Opsin Phosphorylation and Improves Quantum Catch in Retinoid-deficient Mouse Rod Photoreceptors* , 2002, The Journal of Biological Chemistry.
[11] P. Gouras,et al. Retinal degeneration and RPE transplantation in Rpe65(-/-) mice. , 2002, Investigative ophthalmology & visual science.
[12] S. Hanein,et al. Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2) , 2002, The journal of gene medicine.
[13] P. Detwiler,et al. Recovery of Visual Functions in a Mouse Model of Leber Congenital Amaurosis* , 2002, The Journal of Biological Chemistry.
[14] P. Luthert,et al. Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus , 2002, Vision Research.
[15] R. Samulski,et al. Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.
[16] R. Ali,et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. , 2001, Human molecular genetics.
[17] P. Gouras,et al. Ultraviolet and middle wavelength sensitive cone responses in the electroretinogram (ERG) of normal and Rpe65 −/− mice , 2001, Vision Research.
[18] C. Grimm,et al. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis , 2001, Nature Genetics.
[19] R. Rando,et al. The biochemistry of the visual cycle. , 2001, Chemical reviews.
[20] Jean Bennett,et al. Gene therapy restores vision in a canine model of childhood blindness , 2001, Nature Genetics.
[21] F. Liang,et al. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] B. Illi,et al. Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo , 2000, Gene Therapy.
[23] B. Lorenz,et al. Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. , 2000, Investigative ophthalmology & visual science.
[24] T. Aleman,et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Hunt,et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy , 2000, Nature Genetics.
[26] Kotoku Kurachi,et al. Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer , 2000, Journal of Virology.
[27] T. Townes,et al. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. Traboulsi,et al. Mutational analysis and clinical correlation in Leber congenital amaurosis , 2000, Ophthalmic genetics.
[29] I. Constable,et al. Distribution of cathepsin D in human eyes with or without age-related maculopathy. , 1999, Experimental eye research.
[30] A. Munnich,et al. Leber congenital amaurosis. , 1999, Molecular genetics and metabolism.
[31] T. Aleman,et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] B. Byrne,et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.
[33] A. Munnich,et al. Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital amaurosis. , 1999, American journal of human genetics.
[34] K. Narfström,et al. Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65. , 1999, Genomics.
[35] I. Constable,et al. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. , 1999, Human gene therapy.
[36] D. Bok,et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle , 1998, Nature Genetics.
[37] K. Ray,et al. Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. , 1998, Molecular vision.
[38] C. Hamel,et al. Rat messenger RNA for the retinal pigment epithelium‐specific protein RPE65 gradually accumulates in two weeks from late embryonic days 1 , 1998, FEBS letters.
[39] V. Sandig,et al. Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFκB , 1998, Journal of Virology.
[40] Birgit Lorenz,et al. Mutations in RPE65 cause autosomal recessive childhood–onset severe retinal dystrophy , 1997, Nature Genetics.
[41] E. Zrenner,et al. Mutations in RPE65 cause Leber's congenital amaurosis , 1997, Nature Genetics.
[42] R. Samulski,et al. AAV as a viral vector for human gene therapy , 1995, Molecular biotechnology.
[43] K. Narfström,et al. Slowly progressive changes of the retina and retinal pigment epithelium in briard dogs with hereditary retinal dystrophy , 1994, Documenta Ophthalmologica.
[44] M. Naash,et al. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Harris,et al. A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina , 1993, Journal of neuroscience research.
[46] K. Narfström,et al. Ultrastructural changes of the retina and the retinal pigment epithelium in Briard dogs with hereditary congenital night blindness and partial day blindness. , 1992, Experimental eye research.
[47] R. Scharfmann,et al. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[48] E. Rakoczy,et al. In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. , 2003, The Journal of heredity.
[49] K. Narfström,et al. Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber's congenital amaurosis. , 2003, Advances in experimental medicine and biology.
[50] W. Rascher,et al. Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero , 2002, The journal of gene medicine.
[51] C. Hamel,et al. [46] Genetic analysis of RPE65: From human disease to mouse model , 2000 .
[52] C. Hamel,et al. Genetic analysis of RPE65: from human disease to mouse model. , 2000, Methods in enzymology.
[53] B. Ekesten,et al. Hereditary retinal dystrophy in the briard dog: clinical and hereditary characteristics , 1994 .
[54] C. Bridges. Retinoids in Photosensitive Systems , 1984 .